Antibodies against Plasmodium falciparum erythrocyte membrane protein-1 that correlate with protection from severe malaria in children
Background Plasmodium falciparum erythrocyte membrane protein-1 (PfEMP1) are multidomain variant antigens on P. falciparum- infected erythrocytes (IE) that mediate vascular sequestration. Expression of specific PfEMP1 are upregulated in severe malaria (SM), and IgG against them has been linked to protection. The Fc features of PfEMP1-specific antibodies that correlate with protection from severe malaria are not well defined. A combination of PfEMP1 antibody targets and Fc features may distinguish between children with SM and UM. Methods We measured antibodies against 28 PfEMP1 antigen domains in Papua New Guinean children with SM (n = 141) or UM (n = 68), at presentation and eight weeks convalescence. We measured IgG, IgG subclasses, Fc receptor and C1q binding, and measured antibody dependent THP-1 cell and neutrophil phagocytosis (ADNP) of IEs. Results At presentation, UM was positively associated with IgG, IgG1, IgG3 and FcγRIII binding antibodies, against domains that bind endothelial protein C receptor (EPCR), intercellular adhesion molecule-1 (ICAM-1) or CD36, and with ADNP of IE that bind ICAM-1 and CD36 (two-fold difference in mean antibodies, p-value range 0.03 to 10 − 10 ). Associations were most notable when compared to children with severe anaemia. By convalescence, FcγRIIIb and FcγRIIb binding antibodies declined while C1q binding antibodies increased. Using Elastic Net Regression modelling, functional antibodies targeting diverse PfEMP1 domains distinguished between SM or UM with 84% accuracy (77–89%), whereas using only EPCR binging variants achieved 66% (57–74%). Using Tensor-structured decomposition, variation between SM and UM was driven by functional antibodies against all PfEMP1 domains. Conclusions IgG1 and IgG3 antibodies that engage Fc receptors and target EPCR, ICAM-1 and CD36 binding domains, and ADNP of IE, may protect from SM. Accurate classification of SM and UM requires functional antibody measures to a combination of PfEMP1 domains of multiple binding phenotypes, and deficiencies in antibodies vary between SM presentations. Interventions to prevent SM or biomarker panels to predict protective immunity may need to include a breadth of PfEMP1 variant targets.
Authors
- Eizo Takashima (ORCID: https://orcid.org/0000-0001-9070-8499)
- Daniel Getacher Feleke (ORCID: https://orcid.org/0000-0003-2339-106X)
- Aaron S. Meyer (ORCID: https://orcid.org/0000-0003-4513-1840)
- Laurens A. Manning (ORCID: https://orcid.org/0000-0003-4334-5351)
- Louise Turner (ORCID: https://orcid.org/0000-0003-4494-2289)
- Yvonne Adams (ORCID: https://orcid.org/0000-0001-8041-6580)
- Moses Laman (ORCID: https://orcid.org/0000-0003-0964-805X)
- Anja T. R. Jensen (ORCID: https://orcid.org/0000-0002-4004-7554)
- Isobel S. Walker (ORCID: https://orcid.org/0000-0002-3071-1212)
- Elvin Lufele (ORCID: https://orcid.org/0000-0003-1512-2556)
- Thomas Lavstsen (ORCID: https://orcid.org/0000-0002-3044-4249)
- Wina Hasang (ORCID: https://orcid.org/0000-0001-8664-7558)
- Ivo Müeller (ORCID: https://orcid.org/0000-0001-6554-6889)
- Timothy M. E. Davis (ORCID: https://orcid.org/0000-0003-0749-7411)
- Stephen John Rogerson (ORCID: https://orcid.org/0000-0003-4287-1982)
- Elizabeth H. Aitken (ORCID: https://orcid.org/0000-0002-2677-6208)
- Janavi S. Rambhatla
- Julie Anne Simpson (ORCID: https://orcid.org/0000-0002-2660-2013)
- Takafumi Tsuboi (ORCID: https://orcid.org/0000-0002-7415-1325)
- Michael F. Duffy (ORCID: https://orcid.org/0000-0001-5635-4033)
- Amy W. Chung (ORCID: https://orcid.org/0000-0003-0020-9704)
- J. Alexandra Rowe (ORCID: https://orcid.org/0000-0002-7702-1892)
- Megha Rajasekhar (ORCID: https://orcid.org/0000-0003-0665-6919)
- Rebecca W. Olsen (ORCID: https://orcid.org/0000-0003-4034-4302)
- Ali Haghiri (ORCID: https://orcid.org/0000-0002-6008-3165)
- Stanley E Otoboh
- O. B. Williams
- Amaya Ortega Pajares
Institutions
- University of Copenhagen (DK)
- Burnet Institute (AU)
- The University of Melbourne (AU)
- The University of Western Australia (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Ehime University (JP)
- Massachusetts Institute of Technology (US)
- Papua New Guinea Institute of Medical Research (PG)
- University of Edinburgh (GB)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-19
- DOI
- https://doi.org/10.21203/rs.3.rs-11383498/v1
- Primary Topic
- Malaria Research and Control
- Type
- preprint